These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 9772380)
1. [The role of adenosine in the central nervous system]. Zhang WL; Lu GW Sheng Li Ke Xue Jin Zhan; 1996 Oct; 27(4):313-8. PubMed ID: 9772380 [TBL] [Abstract][Full Text] [Related]
2. Neuroprotective role of adenosine in the CNS. Wardas J Pol J Pharmacol; 2002; 54(4):313-26. PubMed ID: 12523485 [TBL] [Abstract][Full Text] [Related]
4. [Adenosine--neurotransmitter and neuromodulator in the central nervous system]. Romanowska M; Komoszyński M Postepy Biochem; 2002; 48(3):230-8. PubMed ID: 12625251 [No Abstract] [Full Text] [Related]
6. [The mechanisms of depression by benzodiazepines, barbiturates and propofol of excitatory synaptic transmissions mediated by adenosine neuromodulation]. Narimatsu E; Niiya T; Kawamata M; Namiki A Masui; 2006 Jun; 55(6):684-91. PubMed ID: 16780077 [TBL] [Abstract][Full Text] [Related]
7. Cross-talk between adenosine and opioid receptors. Peart JN; Gross GJ Drug News Perspect; 2005 May; 18(4):237-42. PubMed ID: 16034479 [TBL] [Abstract][Full Text] [Related]
8. Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Cunha RA Neurochem Int; 2001 Feb; 38(2):107-25. PubMed ID: 11137880 [TBL] [Abstract][Full Text] [Related]
10. Differential effect of adenosine on tumor and normal cell growth: focus on the A3 adenosine receptor. Ohana G; Bar-Yehuda S; Barer F; Fishman P J Cell Physiol; 2001 Jan; 186(1):19-23. PubMed ID: 11147810 [TBL] [Abstract][Full Text] [Related]
11. Purinergic dysfunction in mania: an integrative model. Machado-Vieira R; Lara DR; Souza DO; Kapczinski F Med Hypotheses; 2002 Apr; 58(4):297-304. PubMed ID: 12027524 [TBL] [Abstract][Full Text] [Related]
12. Involvement of P2 receptors in the growth and survival of neurons in the CNS. Franke H; Illes P Pharmacol Ther; 2006 Mar; 109(3):297-324. PubMed ID: 16102837 [TBL] [Abstract][Full Text] [Related]
13. Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes. Bishnoi M; Chopra K; Kulkarni SK Eur J Pharmacol; 2006 Dec; 552(1-3):55-66. PubMed ID: 17064683 [TBL] [Abstract][Full Text] [Related]
14. Purinergic inhibition of neurotransmitter release in the central nervous system. Ribeiro JA Pharmacol Toxicol; 1995 Nov; 77(5):299-305. PubMed ID: 8778740 [TBL] [Abstract][Full Text] [Related]
15. [Function of adenosine receptors in the central nervous system]. Kuwana Y Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):991-5. PubMed ID: 10771663 [No Abstract] [Full Text] [Related]
16. Influences of adenosine on the fetus and newborn. Rivkees SA; Zhao Z; Porter G; Turner C Mol Genet Metab; 2001; 74(1-2):160-71. PubMed ID: 11592813 [TBL] [Abstract][Full Text] [Related]
17. Adenosine as a neuromodulator. Snyder SH Annu Rev Neurosci; 1985; 8():103-24. PubMed ID: 2858998 [No Abstract] [Full Text] [Related]
18. Modulation of apoptosis by adenosine in the central nervous system: a possible role for the A3 receptor. Pathophysiological significance and therapeutic implications for neurodegenerative disorders. Abbracchio MP; Ceruti S; Brambilla R; Franceschi C; Malorni W; Jacobson KA; von Lubitz DK; Cattabeni F Ann N Y Acad Sci; 1997 Oct; 825():11-22. PubMed ID: 9369971 [No Abstract] [Full Text] [Related]
19. [Adenosine and its neuronal receptors]. Malec D Postepy Hig Med Dosw; 1991; 45(6):497-508. PubMed ID: 1687611 [TBL] [Abstract][Full Text] [Related]